Regeneron Pharmaceuticals' CEO said Tuesday the company hopes to have its COVID-19 treatment ready for human testing by August. Leonard Schleifer, in an interview Tuesday on CNBC, said the company could have 200,000 doses ready by August, and that it would pursue both clinical trials and drug manufacturing simultaneously.
Trending:
Regeneron hopes to have COVID-19 treatment by summer for testing